pillbase.ru

Ngenla

Active substance: somatrogon

somatrogon

Centralised EU authorisationActive

Marketing holder: Pfizer Europe MA EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Ngenla
    INJECTION, SOLUTION · SOMATROGON 60 mg/1.2mL
    0069-0520
    Pfizer Laboratories Div Pfizer Inc
  • Ngenla
    INJECTION, SOLUTION · SOMATROGON 24 mg/1.2mL
    0069-0505
    Pfizer Laboratories Div Pfizer Inc
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-3e12-7443-b94b-4c895d3204c2,01a1208f-559d-703c-bb4e-2f414acf96fa;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005633
Registration status
Active
ATC code
H01AC08
Sources
  • product · EMA · EMEA/H/C/005633 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005633 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005633 · Verified 2026-10-09